EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.4.3 | wild-type and mutant CFTR are transiently expressed in HeLa cell membranes a double vaccinia virus/T7 RNA polymerase system | Homo sapiens |
5.6.1.6 | transient expression of either wild-type or mutant enzymes in HeLa cell membranes using a vaccinia virus/T7 RNA polymerase expression system | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
5.6.1.6 | A462F | site-directed mutagenesis, the mutation abolishes nucleotide interaction with ATP-binding site 1, the mutant exhibits a low, ATP-dependent open probability due to a reduced opening rate with a normal burst duration. The A462F mutation interfers with processing and trafficking to the cell membrane | Homo sapiens |
5.6.1.6 | D1370N | site-directed mutagenesis of a conserved residue in the Walker B motif of ATP-binding site 2, the mutation abolishes P1,P5-di(adenosine-5') pentaphosphate, Ap5A, inhibition of current | Homo sapiens |
5.6.1.6 | D572N | site-directed mutagenesis of a conserved residue in the Walker B motif of ATP-binding site 1, the mutation does not abolish P1,P5-di(adenosine-5') pentaphosphate, Ap5A, inhibition of current | Homo sapiens |
5.6.1.6 | K1250A | site-directed mutagenesis of a conserved residue in the Walker A motif of ATP-binding site 2, the mutation abolishes P1,P5-di(adenosine-5') pentaphosphate, Ap5A, inhibition of current | Homo sapiens |
5.6.1.6 | K464A | site-directed mutagenesis of a conserved residue in the Walker A motif of ATP-binding site 1, the mutation does not abolish P1,P5-di(adenosine-5') pentaphosphate, Ap5A, inhibition of current | Homo sapiens |
5.6.1.6 | additional information | photolabeling of CFTR with 8-N3-[32P]AMP or 8-N3-[32P]ATP | Homo sapiens |
5.6.1.6 | S1248F | site-directed mutagenesis, the mutation abolishes nucleotide interaction with ATP-binding site 2, the mutant exhibits a low, ATP-dependent open probability due to a reduced opening rate with a normal burst duration. The S1248F mutation does not interfere with processing and trafficking to the cell membrane | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.4.3 | P1,P4-di(adenosine-5') tetraphosphate | Ap4A | Homo sapiens | |
2.7.4.3 | P1,P5-di(adenosine-5') pentaphosphate | Ap5A, interacts simultaneously with an AMP-binding site and ATP-binding site 2 | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
5.6.1.6 | membrane | - |
Homo sapiens | 16020 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.7.4.3 | Mg2+ | required | Homo sapiens | |
5.6.1.6 | Mg2+ | required | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.4.3 | ATP + AMP | Homo sapiens | - |
2 ADP | - |
r | |
2.7.4.3 | additional information | Homo sapiens | the cystic fibrosis transmembrane conductance regulator (CFTR) has adenylate kinase activity as an ABC adenylate kinase. ATP enables CFTR photolabeling by 8-N3-AMP, and AMP increases 8-N3-ATP photolabeling at ATP-binding site 2. AMP interacts with CFTR in an ATP-dependent manner and alters ATP interaction with the adenylate kinase active center ATP-binding site. Two other ABC proteins, Rad50 and a structural maintenance of chromosome protein, also have adenylate kinase activity. All three ABC adenylate kinases bind and hydrolyze ATP in the absence of other nucleotides | ? | - |
? | |
5.6.1.6 | ATP + H2O + closed Cl- channel | Homo sapiens | - |
ADP + phosphate + open Cl- channel | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.4.3 | Homo sapiens | - |
- |
- |
5.6.1.6 | Homo sapiens | P13569 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.4.3 | ATP + AMP | - |
Homo sapiens | 2 ADP | - |
r | |
2.7.4.3 | additional information | the cystic fibrosis transmembrane conductance regulator (CFTR) has adenylate kinase activity as an ABC adenylate kinase. ATP enables CFTR photolabeling by 8-N3-AMP, and AMP increases 8-N3-ATP photolabeling at ATP-binding site 2. AMP interacts with CFTR in an ATP-dependent manner and alters ATP interaction with the adenylate kinase active center ATP-binding site. Two other ABC proteins, Rad50 and a structural maintenance of chromosome protein, also have adenylate kinase activity. All three ABC adenylate kinases bind and hydrolyze ATP in the absence of other nucleotides | Homo sapiens | ? | - |
? | |
5.6.1.6 | ATP + H2O + closed Cl- channel | - |
Homo sapiens | ADP + phosphate + open Cl- channel | - |
? | |
5.6.1.6 | additional information | in the presence of ATP and physiologically relevant concentrations of AMP, the enzyme exhibits adenylate kinase activity, converting ATP and AMP into 2 ADP and vice versa. The interaction of nucleotide triphosphate with the enzyme at ATP-binding site 2 is required for this activity. ATP and AMP interact with separate binding sites but mutually influence their interaction with the ABC adenylate kinase CFTR, the active center of the adenylate kinase comprises ATP-binding site 2 | Homo sapiens | ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
5.6.1.6 | More | construction of a putative molecular three-dimensional model of the nucleotide-binding domain 1-nucleotide-binding domain 2 heterodimer | Homo sapiens |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.4.3 | ABC adenylate kinase | - |
Homo sapiens |
5.6.1.6 | CFTR | - |
Homo sapiens |
5.6.1.6 | cystic fibrosis transmembrane conductance regulator | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
5.6.1.6 | 23 | 26 | assay at room temperature | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.7.4.3 | 7.5 | - |
assay at | Homo sapiens |
5.6.1.6 | 7.3 | - |
assay at | Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.4.3 | additional information | ATP and AMP interact with separate binding sites but mutually influence their interaction with the ABC adenylate kinase CFTR. The active center of an adenylate kinase comprises separate ATP- and AMP-binding sites, and comprises ATP-binding site 2. Construction of a three-dimensional model of the CFTR NBD1-NBD2 heterodimer, molecular modelling with bound ATP molecules, overview | Homo sapiens |
5.6.1.6 | evolution | the enzyme is an ATP-binding cassette (ABC) adenylate kinase and anion channel in the ATP-binding cassette (ABC) transporter protein family | Homo sapiens |
5.6.1.6 | additional information | photolabeling of CFTR with 8-N3-[32P]AMP or 8-N3-[32P]ATP, with a photoactivatable azido (N3)-group attached to the adenine ring, the photolabeling is enhanced by AMP and inhibited by P1,P4-di(adenosine-5') tetraphosphate and P1,P5-di(adenosine-5') pentaphosphate, which do not interact with all CFTR ATP-binding sites. Specific labeling of an AMP-binding site in the presence of ATP. Construction of a putative molecular three-dimensional model of the nucleotide-binding domain 1-nucleotide-binding domain 2 heterodimer, the crystal structure of NBD1 in complex with ATP (PDB code 1R0X) is used as template for constructing a homology model of NBD2 | Homo sapiens |
5.6.1.6 | physiological function | the enzyme is an ATP-binding cassette adenylate kinase and anion channel | Homo sapiens |